147 related articles for article (PubMed ID: 26233771)
1. Predictive Value of the No-Reflow Phenomenon and Epicardial Adipose Tissue for Clinical Outcomes After Primary Percutaneous Coronary Intervention.
Zencirci AE; Zencirci E; Değirmencioğlu A; Erdem A; Karakuş G; Özden K; Karadeniz F; Buturak A; Belen E; Tipi F; Eren M
Hellenic J Cardiol; 2015; 56(4):311-9. PubMed ID: 26233771
[TBL] [Abstract][Full Text] [Related]
2. The relationship between epicardial adipose tissue and ST-segment resolution in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zencirci E; Zencirci AE; Değirmencioğlu A; Karakuş G; Uğurlucan M; Özden K; Erdem A; Güllü AÜ; Ekmekçi A; Velibey Y; Erer HB; Çelik S; Akyol A
Heart Vessels; 2015 Mar; 30(2):147-53. PubMed ID: 24413852
[TBL] [Abstract][Full Text] [Related]
3. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Lei L; Ye H; Peng J
Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Buyukkaya E; Poyraz F; Karakas MF; Kurt M; Akcay AB; Akpinar I; Motor S; Turak O; Ozturk OH; Sen N; Akpek M; Kaya MG; Gibson CM
Am J Cardiol; 2013 Jul; 112(2):187-93. PubMed ID: 23601576
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
[TBL] [Abstract][Full Text] [Related]
7. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
[TBL] [Abstract][Full Text] [Related]
8. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
[TBL] [Abstract][Full Text] [Related]
9. The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Murat SN; Kurtul A; Celik IE; Duran M; Yarlioglues M; Kilic A; Elcik D
Coron Artery Dis; 2016 Mar; 27(2):116-21. PubMed ID: 26709984
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
[TBL] [Abstract][Full Text] [Related]
11. Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention.
Tang L; Fang ZF; Zhou SH; Tai S; Ahmed S; Huang F; Shen XQ; Zhao YS; Hu XQ
Heart Vessels; 2016 Sep; 31(9):1456-66. PubMed ID: 26498756
[TBL] [Abstract][Full Text] [Related]
12. Increased Epicardial Adipose Tissue Thickness is Associated With Angiographic Thrombus Burden in the Patients With Non-ST-Segment Elevation Myocardial Infarction.
Bakirci EM; Degirmenci H; Duman H; Inci S; Hamur H; Buyuklu M; Ceyhun G; Topal E
Clin Appl Thromb Hemost; 2015 Oct; 21(7):612-8. PubMed ID: 25381157
[TBL] [Abstract][Full Text] [Related]
13. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.
Şahin DY; Gür M; Elbasan Z; Kuloğlu O; Şeker T; Kivrak A; Tanboğa İH; Gözübüyük G; Kirim S; Çayli M
Coron Artery Dis; 2013 Mar; 24(2):148-53. PubMed ID: 23363986
[TBL] [Abstract][Full Text] [Related]
14. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
15. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
[TBL] [Abstract][Full Text] [Related]
16. Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue.
Mohamed A
Clin Cardiol; 2021 Oct; 44(10):1371-1376. PubMed ID: 34255859
[TBL] [Abstract][Full Text] [Related]
17. Epicardial Adipose Tissue and No-Reflow Phenomenon: Adipokines as Regulators of Coronary Microcirculation?
Antonopoulos AS; Antoniades C; Tousoulis D
Hellenic J Cardiol; 2015; 56(4):320-3. PubMed ID: 26233772
[No Abstract] [Full Text] [Related]
18. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
[TBL] [Abstract][Full Text] [Related]
19. The relationship between Gensini score and ST-segment resolution in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zencirci AE; Zencirci E; Degirmencioglu A; Karakus G; Ugurlucan M; Gunduz S; Ozden K; Erdem A; Karadeniz F; Ekmekci A; Erer H; Sayar N; Eren M
Kardiol Pol; 2014; 72(6):494-503. PubMed ID: 24408069
[TBL] [Abstract][Full Text] [Related]
20. The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Somuncu MU; Akgun T; Cakır MO; Akgul F; Serbest NG; Karakurt H; Can M; Demir AR
J Atheroscler Thromb; 2019 Nov; 26(11):970-978. PubMed ID: 30996145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
